Alkem

Alkem launches Pertuza in India to treat HER2-positive breast cancer

Read more

Industry growth weakens sharply in Mar’24

Read more

Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections

Read more

Enzene Biosciences launches Cetuximab, biosimilar of cancer drug Erbitux

Read more

US FDA completes inspection of Alkem’s manufacturing facility in Indore

Read more

Alkem becomes first Indian company to launch novel antibiotic for MDR infections

Read more

Alkem launches breast cancer treatment drug palbociclib (Palbo) in India

Read more

Redefining job roles to build competitive compliance

Read more

Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam)

Read more

Alkem launches favipiravir under brand name Alfluenza

Read more